1. Home
  2. MPU vs SRTS Comparison

MPU vs SRTS Comparison

Compare MPU & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MPU

Mega Matrix Corp.

HOLD

Current Price

$0.31

Market Cap

42.4M

ML Signal

HOLD

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$2.85

Market Cap

46.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPU
SRTS
Founded
1989
2010
Country
Singapore
United States
Employees
N/A
N/A
Industry
Transportation Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.4M
46.9M
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
MPU
SRTS
Price
$0.31
$2.85
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.00
AVG Volume (30 Days)
73.6K
98.5K
Earning Date
04-16-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,482,000.00
Revenue This Year
N/A
$2.00
Revenue Next Year
N/A
$34.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$2.66
52 Week High
$4.44
$5.92

Technical Indicators

Market Signals
Indicator
MPU
SRTS
Relative Strength Index (RSI) 23.31 28.58
Support Level N/A N/A
Resistance Level $1.00 $3.62
Average True Range (ATR) 0.06 0.21
MACD -0.02 -0.03
Stochastic Oscillator 10.78 17.31

Price Performance

Historical Comparison
MPU
SRTS

About MPU Mega Matrix Corp.

Mega Matrix Corp is a holding company that offers investors an opportunity to participate in the growth of stablecoins, one of the fastest-evolving sectors in digital assets. The company generated revenue from the Membership and top-up streaming services revenue, Online advertising services, and Content licensing. Geographically, the company operates in the United States and Canada, Asia Pacific, Europe middle east and Africa, and Latin America.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: